Psoriasis is a common, chronic, and inflammatory skin disease with a high burden on
individuals, health systems, and society worldwide. With the immunological pathologies and …

Psoriasis is a chronic, autoimmune, and non-communicable skin disease with a worldwide
prevalence rate of 2–3%, creating an economic burden on global health. Some significant …

Pain is one of the classical signs of the inflammatory process in which sensitization of the
nociceptors is the common denominator. This sensitization causes hyperalgesia or allodynia …

Objective The advent of tumor necrosis factor (TNF)–blocking drugs has provided
rheumatologists with an effective, but highly expensive, treatment for the management of …

Psoriasis vulgaris is a multi-factorial heritable disease characterized by severe inflammation
resulting in poorly differentiated, hyperproliferative keratinocytes. Recent advances in …

Background & Aims Physicians frequently encounter patients with immune-mediated
diseases and a history of malignancy. There are limited data on the safety of …

Tumor necrosis factor-α (TNFα) inhibition is effective in the treatment of moderate-to-severe
psoriasis. We report on 120 patients from the literature including six new patients (three …

Objective: To evaluate the efficacy of anti-tumour necrosis factor (TNF) treatments (given for
rheumatological manifestations) in reducing uveitis flares in patients with …

Objective The aim of this systematic review and meta-analysis of longitudinal studies was to
ascertain to effects of TNF-α inhibitor therapy on body weight and BMI. Methods Three …

TNF is a key proinflammatory and immunoregulatory cytokine whose deregulation is
associated with the development of autoimmune diseases and other pathologies. Recent …